A pharmacy-network agreement is not simply a ticket into a payer network. It is an operating document that can shape claim payment, audit exposure, data handling, and the amount of notice a pharmacy receives before key terms change. Before signing or renewing, an owner should translate the agreement into three things: a legal risk map, a financial model, and an operational work plan.
Answer first: Do not review a PBM or network contract as a single reimbursement number. Review the complete agreement, incorporated provider manual, fee schedules, amendment process, appeal rules, and all documents that determine what the pharmacy will actually be paid or required to do. Then have qualified health-care counsel and an experienced pharmacy reimbursement professional test the terms against the pharmacy’s state, payer mix, acquisition-cost data, workflow capacity, and strategic goals.
This article is educational and is not legal, tax, reimbursement, or business advice. Contract enforceability and regulatory requirements depend on the agreement, payer, program, and jurisdiction. Seek advice from qualified counsel and an experienced reimbursement professional before acting.
Key takeaways
- Reimbursement formulas, fees, reconciliation methods, and appeal rights should be read together—not as isolated contract paragraphs.
- Ask for every incorporated document, including manuals, schedules, network addenda, amendment notices, and current appeal instructions.
- Model terms with the pharmacy’s own claims mix and acquisition-cost evidence; a favorable-looking average can conceal a loss-making segment.
- State protections can be material, but they vary. California’s audit and MAC provisions, for example, are not a national rule.
- For Medicare Part D arrangements, identify which current CMS requirements apply to the particular network and operational workflow.
Documents to request before the review meeting
A review is only as good as the record supplied to the reviewers. Request the clean execution copy and every document it incorporates by name, version, or web link. In addition to the agreement and addenda, ask for the current provider manual, reimbursement exhibits, appeal forms, audit policy, credentialing checklist, network directory requirements, claims-submission specifications, and the most recent amendment notice. If a PSAO participates in the relationship, request the PSAO agreement and any document that explains which party is responsible for contracting, payment support, notices, or appeals.
For financial modeling, assemble a defined historical file rather than a handful of memorable claims. A useful file can include paid-claim detail, reversals, remittance information, acquisition-cost records, wholesaler invoices where appropriate, and documented post-adjudication adjustments. Protect patient information and follow the pharmacy’s privacy and security procedures when preparing material for an outside reviewer. The objective is not to predict every future claim. It is to identify which contract mechanisms can move payment after the point of sale and which product, payer, or workflow segments deserve closer attention.
For operations, turn each duty into a calendar, an owner, and an evidence location. For example, if an agreement requires a credential renewal or a response to a portal notice, identify the person who watches the notice channel, the backup person, the deadline, and the record that proves completion. This small discipline is often more valuable than a broad assurance that the pharmacy is “compliant.” It also makes it easier to hand an organized file to counsel or a reimbursement consultant if a dispute develops.
What needs legal review, financial modeling, or operational review?
Legal review: incorporation by reference, amendments, audit and recoupment rights, confidentiality, data use, indemnity, limitations of liability, termination, arbitration, governing law, and venue. Financial modeling: ingredient-cost methodology, dispensing and administrative fees, MAC treatment, effective-rate calculations, reconciliation cadence, offsets, and appeal economics. Operational review: credentialing, record retention, notice monitoring, claims reversals, portal workflows, patient communications, delivery documentation, and audit response. Some provisions belong in all three lanes. An audit clause, for example, is a legal allocation of rights, a potential financial exposure, and an operational documentation obligation.
Why a contract review needs more than a reimbursement rate
PBMs perform functions that include claims processing, network creation, formulary management, drug-utilization review, and management of mail-order or specialty-pharmacy operations, according to the National Association of Insurance Commissioners (NAIC). That breadth matters to a community pharmacy because a network agreement may connect payment terms to operational rules that live outside the signature page: provider manuals, credentialing packets, electronic portals, audit policies, and future amendments.
The Federal Trade Commission’s July 2024 interim staff report put PBM market structure and its implications for pharmacies under national scrutiny. That report is useful context, not a substitute for reading a particular agreement. A contract can differ by payer, line of business, state, network, product category, and date. The most useful owner question is therefore not “What do PBM contracts usually say?” It is “What documents control this relationship, and what would each one do to our pharmacy if the contract is renewed tomorrow?”
Start with a document inventory. Request the executed agreement; all exhibits and addenda; the provider manual and its version date; reimbursement schedules; maximum allowable cost (MAC) appeal instructions; audit and recoupment policies; credentialing requirements; notices of amendments; and, where applicable, PSAO documents that affect the pharmacy’s network participation. Confirm which document prevails if terms conflict. If a term is described only in a portal, save a dated copy and ask how the pharmacy will be notified when it changes.
A three-lens contract-review framework
1. Legal and regulatory lens
Legal review asks what the document obligates the pharmacy to do, what the other party may change, and which law governs disputes. It is not enough to find an arbitration clause or a termination paragraph. Counsel should assess the entire contract hierarchy, incorporation-by-reference language, notice provisions, amendment rights, confidentiality duties, indemnification, limitation of liability, governing law, venue, record retention, audit procedures, and the scope of any data-use authorization.
State law is especially important because PBM regulation is not uniform. GAO reported in 2024 that the five states it examined had enacted different PBM requirements involving pricing and pharmacy payments, including provisions addressing rebates and payments to pharmacies. NAIC likewise notes that states have used laws addressing licensure, reimbursement, MAC-list transparency, network access, and reporting. Those descriptions establish a state-law landscape; they do not make any one protection nationwide.
California illustrates why specificity matters. Its Business and Professions Code contains pharmacy-audit and MAC provisions that apply under defined circumstances. For qualifying contracts, the statute requires particular audit procedures, describes appeal timing, and requires certain MAC-list information and appeal processes. A California pharmacy should have counsel determine whether and how the provisions apply to its contract. A pharmacy outside California should not assume the same deadlines, recoupment limits, or appeal remedies exist.
2. Financial lens
Financial review asks a different question: can the pharmacy deliver the covered prescription mix under the agreement without an unacceptable cash, margin, or reconciliation risk? The answer requires claim-level modeling, not a generic benchmark. Use a representative period of paid claims, reversals, acquisition costs, dispensing costs, and known post-adjudication adjustments. Separate brand, generic, specialty, limited-distribution, refrigerated, controlled-substance, and high-touch claims when those segments behave differently in the pharmacy.
Inspect reimbursement methodology closely. Depending on the agreement, a claim may reference an ingredient-cost benchmark, a MAC list, a discount from a published benchmark, a dispensing fee, a professional fee, a network fee, an administrative fee, or a later reconciliation methodology. Terms sometimes describe generic or brand effective rates. Those phrases should prompt a modeling exercise: identify the measurement period, included claims, exclusions, exclusions from reconciliation, data source, calculation owner, dispute process, and the timing and mechanism for any debit, credit, offset, or recoupment. Do not assume an effective rate protects a particular claim or that it operates the same way across agreements.
For Medicare Part D, contract review also belongs alongside current CMS operational requirements. CMS states that the CY 2026 Medicare Advantage and Part D final rule includes a requirement that Part D sponsors’ network contracts require pharmacies to enroll in the Medicare Transaction Facilitator Data Module. That is a current program-specific point to confirm with the applicable network; it does not replace review of payment terms. CMS also lists a June 12, 2026 proposed rule concerning the negotiation program and Part D program. Proposed rulemaking should be tracked as proposed—not treated as a present contract requirement.
3. Operational lens
Operational review asks whether the pharmacy can comply reliably. A term may require a particular credential, accreditation, help-desk workflow, claims-submission practice, audit record, delivery documentation, patient outreach process, or response deadline. Assign an accountable owner for each obligation. If no one owns it, the clause is not “covered”; it is a risk waiting for a busy day.
High-risk provisions to map before a signature or renewal
| Provision | Why it matters | Evidence or document to request | Primary reviewer | Warning signs to investigate |
|---|---|---|---|---|
| Reimbursement and dispensing fees | Defines cash flow at claim level. | Schedules, formulas, sample remittances, fee list. | Finance/reimbursement specialist | Undefined benchmark, unexplained fees, missing effective dates. |
| MAC and appeal process | Can determine generic claim economics. | Current MAC access method, appeal form, deadlines, remedy. | Finance + counsel | Short filing window, no reason for denial, unclear resubmission path. |
| Reconciliation or effective-rate terms | May create later debits or credits. | Calculation examples, period, included claims, dispute process. | Finance + counsel | Undefined calculation inputs or unilateral interpretation. |
| Audit, recoupment, and offsets | Affects records, liquidity, and appeal strategy. | Audit policy, lookback period, appeal and offset rules. | Counsel + operations | Broad record request, immediate offset, vague extrapolation language. |
| Amendment and notice rights | Controls how terms may change. | Notice method, opt-out process, archived amendments. | Counsel + operations | Portal-only notice with no workable response period. |
| Termination, renewal, and disputes | Determines exit options and forum. | Termination triggers, cure period, arbitration rules. | Counsel | Asymmetrical termination or unclear renewal deadline. |
| Data, confidentiality, and indemnity | Allocates information and liability risk. | Data-use terms, security requirements, insurance provisions. | Counsel + privacy lead | Open-ended data rights or uncapped obligations without review. |
Questions to ask the PBM or PSAO
- Which documents are incorporated into this agreement, and which one controls if terms conflict?
- What is the complete reimbursement formula by claim type, and when was each schedule last updated?
- How can the pharmacy access current MAC information, appeal a rate, and reverse and resubmit a successful appeal?
- Are there reconciliation, performance, network, or administrative fees outside point-of-sale adjudication?
- What claims are included or excluded from any generic or brand effective-rate calculation?
- What records, delivery evidence, and retention periods does the audit policy require?
- How are amendments delivered, what response is required, and what happens if the pharmacy declines?
- What credentialing, accreditation, insurance, or technology requirements apply today and at renewal?
Before you sign: owner checklist
- Build one complete, dated contract file; do not rely on a verbal description of terms.
- Ask counsel to identify legal, privacy, audit, termination, and dispute issues in the relevant jurisdiction.
- Model reimbursement and later adjustments against a representative claims file.
- Test whether MAC appeals, reversals, documentation, and portal notices can be performed within existing staffing capacity.
- Calendar renewal, opt-out, credentialing, and appeal deadlines with a named owner and backup.
- Document any material clarification in writing before relying on it.
Frequently asked questions
Does a PBM contract always include every provision in the table?
No. The table is a review framework, not a claim about universal contract language. The agreement, addenda, provider manual, payer, and state law determine which provisions apply.
Can a pharmacy rely on a state PBM rule without reviewing the agreement?
No. State law may create protections or requirements, but applicability and remedies depend on the jurisdiction and facts. The contract still needs legal, financial, and operational review.
Who should review a contract?
Use a team: qualified health-care counsel for legal terms, a reimbursement professional or finance lead for payment modeling, and operations leadership for workflow obligations. The owner should retain final decision accountability.
Conclusion
A disciplined contract review does not guarantee a favorable agreement. It does give an independent pharmacy a defensible decision process: identify the documents that control, model the dollars, assign the work, and obtain jurisdiction-specific advice before accepting terms. That is more useful than a generic warning about PBMs—and more durable than a single reimbursement rate.
References
- Centers for Medicare & Medicaid Services. Regulations, Guidance, and Policy Documents. Accessed July 19, 2026. https://www.cms.gov/initiatives/medicare-prescription-drug-affordability/overview/medicare-drug-price-negotiation-program/regulations-guidance-policy-documents
- U.S. Government Accountability Office. Prescription Drugs: Selected States’ Regulation of Pharmacy Benefit Managers. GAO-24-106898. Published March 18, 2024. https://www.gao.gov/products/gao-24-106898
- California Legislative Information. California Business and Professions Code, Chapter 9.5, §§4431-4440. Accessed July 19, 2026. California Legislative Information
- National Association of Insurance Commissioners. Pharmacy Benefit Managers. Last updated June 2, 2025. Accessed July 19, 2026. https://content.naic.org/insurance-topics/pharmacy-benefit-managers
- Federal Trade Commission. Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies. July 2024. https://www.ftc.gov/reports/pharmacy-benefit-managers-report
